ライフサイエンスコーパス: epidermolysis

1 mutations, which show widespread and severe epidermolysis.

2 paired hemidesmosome formation in junctional epidermolysis associated with pyloric atresia/beta4 kera

3 EB) and recessive (RDEB) forms of dystrophic epidermolysis bullosa (DEB) and have subsequently identi

4 The dystrophic forms of epidermolysis bullosa (DEB) are characterized by fragili

5 The dystrophic forms of epidermolysis bullosa (DEB) are due to mutations in the

6 Dystrophic epidermolysis bullosa (DEB) is a blistering skin disease

7 Dystrophic epidermolysis bullosa (DEB) is a family of inherited mec

8 Dystrophic epidermolysis bullosa (DEB) is a family of inherited mec

9 Dystrophic epidermolysis bullosa (DEB) is an inherited mechano-bull

10 Dystrophic epidermolysis bullosa (DEB) is an inherited mechano-bull

11 Dystrophic epidermolysis bullosa (DEB) is an inherited mechanobullo

12 Dystrophic epidermolysis bullosa (DEB) is due to mutations in the t

13 gene COL7A1 encoding for C7 cause dystrophic epidermolysis bullosa (DEB), a genetic mechano-bullous d

14 to underlie different variants of dystrophic epidermolysis bullosa (DEB).

15 L7A1) have been shown to underlie dystrophic epidermolysis bullosa (DEB).

16 inherited blistering skin disease dystrophic epidermolysis bullosa (DEB).

17 Heritable forms of epidermolysis bullosa (EB) are characterized by chronic,

18 Patients with epidermolysis bullosa (EB) do not carry a significantly

19 Epidermolysis bullosa (EB) is a class of intractable, ra

20 Epidermolysis bullosa (EB) is a clinically and genetical

21 Epidermolysis bullosa (EB) is a group of autosomal domin

22 Epidermolysis bullosa (EB) is a group of genetic disorde

23 Epidermolysis bullosa (EB) is a group of mechanobullous

24 Epidermolysis bullosa (EB) is a group of rare genetic di

25 Epidermolysis bullosa (EB) is an inherited, heterogeneou

26 Hereditary epidermolysis bullosa (EB) is associated with skin blist

27 incidence and prevalence of each subtype of epidermolysis bullosa (EB) is essential before clinical

28 Epidermolysis bullosa (EB) pruriginosa is a rare variant

29 Epidermolysis bullosa (EB) simplex is a rare genetic con

30 Epidermolysis bullosa (EB) with late-onset muscular dyst

31 Epidermolysis bullosa (EB), a group of complex heritable

32 The heritable forms of epidermolysis bullosa (EB), a phenotypically heterogeneo

33 s with the inherited skin-blistering disease epidermolysis bullosa (EB), we show that large numbers o

34 caries experience in the different types of epidermolysis bullosa (EB).

35 ases with epidermal loss, such as junctional epidermolysis bullosa (EB).

36 Generalized atrophic benign epidermolysis bullosa (GABEB) is a nonlethal variant of

37 The Herlitz type of junctional epidermolysis bullosa (H-JEB) is a severe blistering dis

38 the skin of patients with Herlitz junctional epidermolysis bullosa (H-JEB).

39 sease Hallopeau-Siemens recessive dystrophic epidermolysis bullosa (HS-RDEB) results from mutations i

40 Junctional forms of epidermolysis bullosa (JEB) are associated with mutation

41 Junctional epidermolysis bullosa (JEB) is a heterogeneous group of

42 Junctional epidermolysis bullosa (JEB) is an autosomal recessive di

43 Junctional epidermolysis bullosa (JEB) is an autosomal recessive sk

44 Junctional epidermolysis bullosa (JEB) is an inherited mechanobullo

45 The blistering disorder, lethal junctional epidermolysis bullosa (JEB), can result from mutations i

46 (GABEB) is a nonlethal variant of junctional epidermolysis bullosa (JEB).

47 In Herlitz junctional epidermolysis bullosa (laminin 5 abnormalities, n = 4) t

48 patients with different forms of junctional epidermolysis bullosa (n = 13).

49 = 3) or with autosomal recessive dystrophic epidermolysis bullosa (n = 4) were included as controls.

50 BP), and absent in patients with one type of epidermolysis bullosa (OMIM #226650).

51 Herlitz junctional epidermolysis bullosa (OMIM#226700) is a lethal, autosom

52 ytes from patients with recessive dystrophic epidermolysis bullosa (RDEB) and normal dermal fibroblas

53 skin blistering disease recessive dystrophic epidermolysis bullosa (RDEB) develop aggressive cutaneou

54 Recessive dystrophic epidermolysis bullosa (RDEB) is a complex inherited skin

55 Recessive dystrophic epidermolysis bullosa (RDEB) is a debilitating genoderma

56 Importance: Recessive dystrophic epidermolysis bullosa (RDEB) is a devastating, often fat

57 The recessive dystrophic form of epidermolysis bullosa (RDEB) is a disorder of incurable

58 Recessive dystrophic epidermolysis bullosa (RDEB) is a genetic skin fragility

59 Recessive dystrophic epidermolysis bullosa (RDEB) is a rare condition in whic

60 Recessive dystrophic epidermolysis bullosa (RDEB) is a rare monogenic blister

61 Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited skin-

62 Recessive dystrophic epidermolysis bullosa (RDEB) is an autosomal recessive d

63 Recessive dystrophic epidermolysis bullosa (RDEB) is an incurable disease cau

64 Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited blistering

65 Recessive dystrophic epidermolysis bullosa (RDEB) is an inherited disorder ch

66 Recessive dystrophic epidermolysis bullosa (RDEB) is caused by defects of typ

67 Recessive dystrophic epidermolysis bullosa (RDEB) is caused by defects of typ

68 ted in vivo utilizing a recessive dystrophic epidermolysis bullosa (RDEB) knockout mouse model.

69 t that individuals with recessive dystrophic epidermolysis bullosa (RDEB) only develop squamous-cell

70 agility disorder coined recessive dystrophic epidermolysis bullosa (RDEB) that is associated with a c

71 plored their utility in recessive dystrophic epidermolysis bullosa (RDEB), a blistering disease due t

72 collagen defects cause recessive dystrophic epidermolysis bullosa (RDEB), a blistering skin disorder

73 s of severe generalized recessive dystrophic epidermolysis bullosa (RDEB), a currently incurable blis

74 Individuals with recessive dystrophic epidermolysis bullosa (RDEB), a rare genetic skin diseas

75 currently available for recessive dystrophic epidermolysis bullosa (RDEB), a severe heritable blister

76 listering skin disorder recessive dystrophic epidermolysis bullosa (RDEB), caused by mutations in the

77 blistering skin disease recessive dystrophic epidermolysis bullosa (RDEB), which is characterized by

78 in patients affected by recessive dystrophic epidermolysis bullosa (RDEB).

79 ting blistering disease recessive dystrophic epidermolysis bullosa (RDEB).

80 ion in individuals with recessive dystrophic epidermolysis bullosa (RDEB).

81 unrelated families with recessive dystrophic epidermolysis bullosa (RDEB).

82 rm of the skin blistering disease dystrophic epidermolysis bullosa (RDEB).

83 Epidermolysis bullosa acquisita (EBA) is a chronic mucoc

84 Epidermolysis bullosa acquisita (EBA) is a prototypic or

85 Epidermolysis bullosa acquisita (EBA) is a rare blisteri

86 Epidermolysis bullosa acquisita (EBA) is an acquired bli

87 Epidermolysis bullosa acquisita (EBA) is an acquired bul

88 Epidermolysis bullosa acquisita (EBA) is an AIBD associa

89 Epidermolysis bullosa acquisita (EBA) is an autoimmune b

90 Epidermolysis bullosa acquisita (EBA) is an autoimmune b

91 Epidermolysis bullosa acquisita (EBA) is an autoimmune b

92 Epidermolysis bullosa acquisita (EBA) is an autoimmune s

93 d against tissue destruction in experimental epidermolysis bullosa acquisita (EBA), an AIBD caused by

94 flammation, we employed immunization-induced epidermolysis bullosa acquisita (EBA), an autoimmune bul

95 In epidermolysis bullosa acquisita (EBA), an autoimmune dis

96 mice that mimic those seen in patients with epidermolysis bullosa acquisita (see the related article

97 evelopment of new therapeutic strategies for epidermolysis bullosa acquisita and related autoimmune d

98 Epidermolysis bullosa acquisita autoantibodies bound to

99 ought to determine if type VII collagen, the epidermolysis bullosa acquisita autoantigen, was present

100 ction crystallizable glycosylation in murine epidermolysis bullosa acquisita in congenic mouse strain

101 Epidermolysis bullosa acquisita is a subepidermal bliste

102 Epidermolysis bullosa acquisita is an autoimmune blister

103 Epidermolysis bullosa acquisita is an autoimmune skin-bl

104 Epidermolysis bullosa acquisita is caused by antibodies

105 immunofluorescence microscopy, not diagnosed epidermolysis bullosa acquisita or anti-laminin-332 muco

106 Furthermore, autoantibodies from epidermolysis bullosa acquisita patients also reacted wi

107 IgG from an epidermolysis bullosa acquisita serum containing autoant

108 -145, were applied to mice with experimental epidermolysis bullosa acquisita, an autoimmune bullous d

109 Systemic diseases are often associated with epidermolysis bullosa acquisita, Crohn's disease being t

110 igus vulgaris/foliaceus, bullous pemphigoid, epidermolysis bullosa acquisita, mucous membrane pemphig

111 action may contribute to the pathogenesis of epidermolysis bullosa acquisita.

112 tise and classified as bullous pemphigoid or epidermolysis bullosa acquisita.

113 e skin of children with recessive dystrophic epidermolysis bullosa after allogeneic bone marrow trans

114 pulation carrier risk for Herlitz junctional epidermolysis bullosa and all variants of junctional epi

115 COL7A1 mutations in patients with dystrophic epidermolysis bullosa and compared them with an establis

116 To explain the milder recessive dystrophic epidermolysis bullosa and junctional epidermolysis bullo

117 f hemophilia, tyrosinemia type I, junctional epidermolysis bullosa and type 1 diabetes.

118 ies underlying different forms of junctional epidermolysis bullosa appear to affect certain critical

119 riasis, infantile hemangiomas and dystrophic epidermolysis bullosa are reviewed.

120 patients with severe generalized junctional epidermolysis bullosa born in the years 2000-2015.

121 s did not have the lethal form of junctional epidermolysis bullosa but, as adults, displayed the mild

122 Treatment of severe generalized junctional epidermolysis bullosa by SCT is a last-ditch attempt sti

123 cells of patients with recessive dystrophic epidermolysis bullosa can be corrected by homology-direc

124 ibrils in patients with recessive dystrophic epidermolysis bullosa can be morphologically altered, re

125 one in 350, respectively, while the overall epidermolysis bullosa carrier frequency was calculated t

126 ement or cell-based therapies for dystrophic epidermolysis bullosa caused by genetic deficiency of co

127 study was performed from 2003 to 2023 at the Epidermolysis Bullosa Centre, University of Freiburg, Ge

128 teeth from patients suffering from recessive epidermolysis bullosa dystrophica (rEBD) in terms of its

129 gene for mutations in 22 Herlitz junctional epidermolysis bullosa families, and identified 15 distin

130 ne responses that may arise in patients with epidermolysis bullosa following BPAG2 gene replacement,

131 r systemic sclerosis or recessive dystrophic epidermolysis bullosa has led to the common finding of s

132 g the manifestations of recessive dystrophic epidermolysis bullosa in humans.

133 The clinical phenotype of junctional epidermolysis bullosa in the proband in this family prob

134 hese results suggest that Herlitz junctional epidermolysis bullosa in this patient developed as a res

135 e cases of the nonlethal forms of junctional epidermolysis bullosa involving abnormalities in laminin

136 e cases of the nonlethal forms of junctional epidermolysis bullosa involving abnormalities in laminin

137 Recessive dystrophic epidermolysis bullosa is a devastating blistering diseas

138 Epidermolysis bullosa is a family of diseases characteri

139 Junctional epidermolysis bullosa is a group of hereditary bullous d

140 Epidermolysis bullosa is a group of heritable skin fragi

141 Herlitz junctional epidermolysis bullosa is a heritable bullous disease cau

142 Dystrophic epidermolysis bullosa is a heritable skin disease manife

143 Junctional epidermolysis bullosa is a heterogeneous autosomal reces

144 Epidermolysis bullosa is a heterogeneous group of herita

145 Dystrophic epidermolysis bullosa is a rare genetic blistering skin

146 Dystrophic epidermolysis bullosa is a rare genetic disease caused b

147 Dystrophic epidermolysis bullosa is a rare genetic skin disorder ca

148 Generalized atrophic benign epidermolysis bullosa is an autosomal recessive subepide

149 Recessive dystrophic epidermolysis bullosa is an incurable, often fatal mucoc

150 Epidermolysis bullosa is caused by mutations in at least

151 total number of distinct Herlitz junctional epidermolysis bullosa mutations in LAMB3 to 35.

152 1 of 150,000, severe generalized junctional epidermolysis bullosa occurred more often than published

153 Patients with generalized atrophic benign epidermolysis bullosa often show decreased expression of

154 ic DNA predicted severe recessive dystrophic epidermolysis bullosa or junctional epidermolysis bullos

155 Advances in our understanding of epidermolysis bullosa pathophysiology have provided the

156 The recessive dystrophic epidermolysis bullosa patients had a homozygous single b

157 gh caries experience in recessive dystrophic epidermolysis bullosa patients is probably related to ot

158 he cDNA were detected, and in the junctional epidermolysis bullosa patients transcripts with in-frame

159 The junctional epidermolysis bullosa patients were compound heterozygot

160 ee techniques we have screened 93 dystrophic epidermolysis bullosa patients yielding an overall sensi

161 Findings in recessive dystrophic epidermolysis bullosa patients' skin were indistinguisha

162 In the recessive dystrophic epidermolysis bullosa patients, transcripts containing i

163 otal of 50 dominant and recessive dystrophic epidermolysis bullosa patients.

164 strophic epidermolysis bullosa or junctional epidermolysis bullosa phenotypes but in whom the manifes

165 trophic epidermolysis bullosa and junctional epidermolysis bullosa phenotypes in these families, reve

166 New epidermolysis bullosa phenotypes, genotypes and modes of

167 A total of 270 of the ~320 COL7A1 epidermolysis bullosa PNVs reside in exons that can be s

168 ts with the distinctive clinical features of epidermolysis bullosa pruriginosa is heterogeneous and s

169 OL7A1 mutation(s), may be responsible for an epidermolysis bullosa pruriginosa phenotype.

170 a distinct clinical subtype of this disease, epidermolysis bullosa pruriginosa, characterized by prur

171 ients consecutively enrolled in the National Epidermolysis Bullosa Registry from January 1, 1986, thr

172 nomic evaluation used data from the National Epidermolysis Bullosa Registry to estimate the current p

173 yses have revealed that recessive dystrophic epidermolysis bullosa results from mutations in the type

174 ng the complete set of genes associated with epidermolysis bullosa revealed a homozygous nonsense mut

175 Through studies that began with epidermolysis bullosa simplex (EBS) and now extend to a

176 Epidermolysis bullosa simplex (EBS) is a group of autoso

177 Importance: Epidermolysis bullosa simplex (EBS) is a group of clinic

178 Epidermolysis bullosa simplex (EBS) is a mechano-bullous

179 Epidermolysis bullosa simplex (EBS) is a rare genetic co

180 Epidermolysis bullosa simplex (EBS) is a rare inherited

181 Epidermolysis bullosa simplex (EBS) is a severe and pote

182 Epidermolysis bullosa simplex (EBS) is an incurable, inh

183 Epidermolysis bullosa simplex (EBS) is an inherited skin

184 The blistering skin disorder epidermolysis bullosa simplex (EBS) results from dominan

185 Mutations in K5 or K14 genes cause epidermolysis bullosa simplex (EBS), a disorder with bli

186 The best-studied skin fragility disorder is epidermolysis bullosa simplex (EBS), an autosomal domina

187 One such disease is epidermolysis bullosa simplex (EBS), caused by mutations

188 ins keratin 5 (K5) or keratin 14 (K14) cause epidermolysis bullosa simplex (EBS), in which basal laye

189 junctions (NMJs) in patients suffering from epidermolysis bullosa simplex (EBS)-muscular dystrophy (

190 ns 5 or 14 are implicated in the etiology of epidermolysis bullosa simplex (EBS).

191 The Dowling-Meara variant of epidermolysis bullosa simplex (EBS-DM) is a severe blist

192 athy type VI (caused by a loss of DST-a) and Epidermolysis bullosa simplex 3 (caused by a loss of DST

193 d in skin lead to human disorders, including epidermolysis bullosa simplex and epidermolytic hyperker

194 Epidermolysis bullosa simplex are dominant disorders of

195 Epidermolysis bullosa simplex associated with late-onset

196 In epidermolysis bullosa simplex associated with plectin mu

197 Epidermolysis bullosa simplex Dowling-Meara (MIM# 131760

198 dy we sequenced these genes in a family with epidermolysis bullosa simplex Dowling-Meara.

199 e K5 head domain residue T150 in cytoplasmic epidermolysis bullosa simplex granules containing R125C

200 The severe Dowling-Meara form of epidermolysis bullosa simplex is caused by dominant-nega

201 istic feature of the skin blistering disease epidermolysis bullosa simplex is keratin filament (KF) n

202 rmation and function with a possible role in epidermolysis bullosa simplex pathogenesis.

203 This is the second epidermolysis bullosa simplex patient reported with a pr

204 We report an epidermolysis bullosa simplex patient with a novel singl

205 Mutations in epidermolysis bullosa simplex patients could interfere w

206 common mutation in the Dowling-Meara form of epidermolysis bullosa simplex patients is the missense m

207 models that more faithfully recapitulate the epidermolysis bullosa simplex phenotype, is advisable be

208 the palmoplantar distribution seen in other epidermolysis bullosa simplex subtypes, extensive herpet

209 7600) is the most severe of the three common epidermolysis bullosa simplex subtypes.

210 plantation could be applied to patients with epidermolysis bullosa simplex with intraepidermal bliste

211 utation P25L in the V1 domain of keratin 5), epidermolysis bullosa simplex with migratory circinate e

212 everal distinct clinical phenotypes, such as epidermolysis bullosa simplex with mottled pigmentation

213 ents suffering from plectinopathy-associated epidermolysis bullosa simplex with muscular dystrophy (E

214 skin from patients with autosomal recessive epidermolysis bullosa simplex with plectin defects (n =

215 r dystrophy associated with skin blistering (epidermolysis bullosa simplex).

216 ing disorders, epidermolytic hyperkeratosis, epidermolysis bullosa simplex, epidermolytic palmoplanta

217 To date, mutant-specific siRNAs for epidermolysis bullosa simplex, pachyonychia congenita an

218 cal vitelliform macular dystrophy (VMD1) and epidermolysis bullosa simplex, type Ogna (EBS1).

219 e motif have been described in patients with epidermolysis bullosa simplex.

220 vidence of phenotype-genotype correlation in epidermolysis bullosa simplex.

221 mutations in either of these genes can cause epidermolysis bullosa simplex.

222 g seen in the genetic disorder Dowling-Meara epidermolysis bullosa simplex.

223 al trials of bone marrow transplantation for epidermolysis bullosa simplex.

224 s in EXPH5 in an autosomal recessive form of epidermolysis bullosa simplex.

225 eness of squamous cell carcinomas arising in epidermolysis bullosa skin.

226 s the limitations in predicting phenotype in epidermolysis bullosa solely based on mutation analysis

227 cutaneous complications in each of the major epidermolysis bullosa subtypes.

228 of COL17A1 disease from autosomal recessive epidermolysis bullosa to autosomal dominant ERED and ide

229 patients with severe generalized junctional epidermolysis bullosa treated with allogeneic stem cell

230 patients with nonlethal forms of junctional epidermolysis bullosa using polymerase chain reaction am

231 patients with nonlethal forms of junctional epidermolysis bullosa using polymerase chain reaction am

232 layed the milder generalized atrophic benign epidermolysis bullosa variant.

233 lysis bullosa and all variants of junctional epidermolysis bullosa was calculated to be one in 781 an

234 t 3 and 6 months in patients with dystrophic epidermolysis bullosa was more likely with topical admin

235 atients with pemphigus, and 79 patients with epidermolysis bullosa were analyzed).

236 an families with generalized atrophic benign epidermolysis bullosa who share the same COL17A1 mutatio

237 riasis, infantile hemangiomas and dystrophic epidermolysis bullosa will be discussed.

238 EB (OMIM# 226650), is a nonlethal variant of epidermolysis bullosa with autosomal recessive inheritan

239 monstrated in patients with a lethal form of epidermolysis bullosa with congenital pyloric atresia (O

240 me ITGB4 mutations in nonlethal phenotype of epidermolysis bullosa with congenital pyloric atresia.

241 Junctional epidermolysis bullosa with congenital pyloric or duodena

242 seven children who had recessive dystrophic epidermolysis bullosa with immunomyeloablative chemother

243 The human autosomal recessive disorder epidermolysis bullosa with muscular dystrophy (MD-EBS) s

244 In junctional epidermolysis bullosa with pyloric atresia (alpha6beta4

245 Epidermolysis bullosa with pyloric atresia (EB-PA), an a

246 Epidermolysis bullosa with pyloric atresia (EB-PA), mani

247 Epidermolysis bullosa with pyloric atresia (EB-PA; OMIM

248 Immunofluorescence studies of junctional epidermolysis bullosa with pyloric atresia (JEB-PA) have

249 rome resembling the human disease junctional epidermolysis bullosa with pyloric atresia (PA-JEB).

250 e report a patient with a form of junctional epidermolysis bullosa with skin fragility and dental ano

251 ave been published in the field of inherited epidermolysis bullosa within the past few years.

252 13 patients with severe recessive dystrophic epidermolysis bullosa yielding a detection sensitivity o

253 umours of patients with Recessive Dystrophic Epidermolysis Bullosa, a disease characterized by chroni

254 an pedigree with generalized atrophic benign epidermolysis bullosa, a distinct nonlethal form of junc

255 Severe generalized junctional epidermolysis bullosa, a lethal hereditary blistering di

256 Patients with generalized atrophic benign epidermolysis bullosa, a usually nonlethal form of junct

257 ing the role of alpha 6 beta 4 in junctional epidermolysis bullosa, an often lethal human disorder wi

258 n a patient with generalized atrophic benign epidermolysis bullosa, and applies a new methodology to

259 is, similar to that seen in human junctional epidermolysis bullosa, and death occurs within a few day

260 molytic palmoplantar keratoderma, junctional epidermolysis bullosa, and dystrophic forms of epidermol

261 ants causing AI in the absence of junctional epidermolysis bullosa, and highlights the shared AI phen

262 helming majority of patients with dystrophic epidermolysis bullosa, and most of them in this Iranian

263 e prototypic heritable blistering disorders, epidermolysis bullosa, and related keratinopathies, in w

264 there is no effective treatment or cure for epidermolysis bullosa, but bone marrow transplantation h

265 variants in LAMB3 cause recessive junctional epidermolysis bullosa, characterized by life-threatening

266 In a distinct autosomal recessive variant of epidermolysis bullosa, EB-MD, life-long skin blistering

267 Generalized atrophic benign epidermolysis bullosa, GABEB (OMIM# 226650), is a nonlet

268 rous sclerosis complex, and several forms of epidermolysis bullosa, genetic research has resulted in

269 losa, a usually nonlethal form of junctional epidermolysis bullosa, have generalized blistering, nail

270 y in generalised severe recessive dystrophic epidermolysis bullosa, in which blood and marrow transpl

271 inherited mechanobullous disease, dystrophic epidermolysis bullosa, is caused by type VII collagen ge

272 cessive blistering skin disorder, junctional epidermolysis bullosa, particularly in the lethal (Herli

273 forms of recessive dystrophic or junctional epidermolysis bullosa, respectively.

274 osa, a distinct nonlethal form of junctional epidermolysis bullosa, using polymerase chain reaction a

275 that is associated with recessive dystrophic epidermolysis bullosa, was unable to form antiparallel d

276 iously disclosed in patients with dystrophic epidermolysis bullosa, we studied how these amino acid s

277 sive cSCCs (n = 71) and recessive dystrophic epidermolysis bullosa-associated cSCCs (n = 11) than in

278 ular and clinical phenotype of patients with epidermolysis bullosa.

279 on seen in patients with dystrophic forms of epidermolysis bullosa.

280 skin blistering disorder Herlitz junctional epidermolysis bullosa.

281 o the chronic blistering disease, dystrophic epidermolysis bullosa.

282 ntified as the candidate gene for dystrophic epidermolysis bullosa.

283 tended family members at risk for junctional epidermolysis bullosa.

284 e to the blistering skin disease, dystrophic epidermolysis bullosa.

285 nts with the recessive dystrophic subtype of epidermolysis bullosa.

286 l junction, diagnostic of Herlitz junctional epidermolysis bullosa.

287 ocyte integrity and resilience in junctional epidermolysis bullosa.

288 idesmosomes was also perturbed in junctional epidermolysis bullosa.

289 c with other variants of dominant dystrophic epidermolysis bullosa.

290 occurs in some blistering disorders such as epidermolysis bullosa.

291 idermolysis bullosa, and dystrophic forms of epidermolysis bullosa.

292 in for mutations in some forms of junctional epidermolysis bullosa.

293 is a clinical variant of dominant dystrophic epidermolysis bullosa.

294 en gene (COL7A1) in patients with dystrophic epidermolysis bullosa.

295 tic syndrome, interstitial lung disease, and epidermolysis bullosa.

296 d bone marrow transplantation for dystrophic epidermolysis bullosa.

297 f gene therapy for junctional and dystrophic epidermolysis bullosa.

298 in of two patients with recessive dystrophic epidermolysis bullosa.

299 ative medicine to cutaneous diseases such as epidermolysis bullosa.

300 fected individuals displayed only mild focal epidermolysis in the spinous layer of palmoplantar epide